Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 11031-11040 of 12013

Page
per page
  1. Tosedostat (CHR2797)
    A4355 Tosedostat (CHR2797)
     1 Citation
    Target: Aminopeptidases
    Summary: Aminopeptidase inhibitor
      ≥40.6 mg/mL
  2. U-104
    A4358 U-104
    Target: Carbonic Anhydrases
    Summary: CAIX inhibitor
      insoluble in H2O; ≥11.5 mg/mL
  3. JNJ-1661010
    A4361 JNJ-1661010
    Summary: FAAH inhibitor,potent and selective
      Soluble in DMSO
  4. Fluvastatin Sodium
    A4363 Fluvastatin Sodium
    Summary: HMG-CoA reductase inhibitor
  5. Safinamide Mesylate
    A4368 Safinamide Mesylate
    Summary: MAO-B inhibitor,potent,selective and reversible
  6. Dalcetrapib (JTT-705, RO4607381)
    A4376 Dalcetrapib (JTT-705, RO4607381)
    Summary: rhCETP inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  7. Lonafarnib
    A4379 Lonafarnib
    Target: FPTase
    Summary: Ftase inhibitor,potent and selective
      ≥31.95 mg/mL
  8. 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    A1500 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    Summary: Substrate of matrix metalloproteinases assay
      ≥48.7 mg/mL
      insoluble in H2O
  9. CA 074
    A1926 CA 074
     2 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      ≥19.17 mg/mL
  10. HBcAg [Hepatitis B virus] (18-27)
    A1140 HBcAg [Hepatitis B virus] (18-27)
    Summary: Indicator of active viral replication
      ≥115.5 mg/mL

Items 11031-11040 of 12013

Page
per page